First rumors about Gilead – Vertex or Gilead – Pfizer merger start circulating

Investor’s Business Daily has suggested today that California-based biotech Gilead could merge with a competitor of comparable size, the most likely companies being Vertex Pharmaceuticals and Pfizer. Rumors about a mega-merger started circulating after CEO John Milligan had resigned. His resignation could encourage Gilead to merge with a group led by a successful CEO such as Jeffrey Leiden (Vertex) or Ian Reed (Pfizer), many analysts have said.

(Source: Investor’s Business Daily)